PARP Combination Therapies: A New Horizon in Prostate Cancer Care

Gain expert insight on the evolving role of PARP inhibitor therapy including in combination with AR-targeting agents for the treatment of advanced prostate cancer by watching an on-demand webcast of a live symposium downloading the accompanying slidesets and reading a commentary of FAQs from the symposium.

Share

Program Content

Activities

PARPi Combinations
PARP Inhibitor Combination Therapies: A New Horizon in Prostate Cancer Care
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 22, 2022

Expires: February 21, 2023

PARPi Monotherapy
Current Use of PARP Inhibitors in Prostate Cancer: Rationale and Key Monotherapy Data
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 22, 2022

Expires: February 21, 2023

Genetic Testing in PCa
Selecting Patients for PARP Inhibitor Therapy: Principles of Genetic Testing
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 23, 2022

Expires: February 22, 2023

No activities added yet

Activities

PARPi in PCa: Key Issues
My Thoughts on Key Issues With PARP Inhibitors for Prostate Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 26, 2022

Expires: April 25, 2023

Faculty

cover img faculity

Wassim Abida, MD, PhD

Director of Translational Research, Prostate Cancer
Associate Member
Genitourinary Oncology Service
Memorial Sloan Kettering Cancer Center
Associate Professor of Medicine
Weill Cornell Medical College
New York, New York

cover img faculity

Heather H. Cheng, MD, PhD

Associate Professor
Department of Medicine (Hematology and Oncology)
University of Washington
Division of Clinical Research
Fred Hutchinson Cancer Center
Seattle, Washington

cover img faculity

Maha Hussain, MD, FACP, FASCO

Genevieve Teuton Professor of Medicine
Division of Hematology/Oncology
Deputy Director
Robert H. Lurie Comprehensive Cancer Center
Northwestern University Feinberg School of Medicine
Chicago, Illinois

Provided by

ProCE Banner

Supporters

Supported by educational grants from

AstraZeneca

Merck Sharp & Dohme Corp.

Pfizer, Inc.